Putnam Investments’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-22,761
| Closed | -$730K | – | 1327 |
|
|
2016
Q4 | $730K | Sell |
22,761
-314,610
| -93% | -$10.1M | ﹤0.01% | 1066 |
|
|
2016
Q3 | $16.9M | Sell |
337,371
-15,245
| -4% | -$762K | 0.04% | 305 |
|
|
2016
Q2 | $15M | Buy |
352,616
+13,136
| +4% | +$557K | 0.04% | 338 |
|
|
2016
Q1 | $22.4M | Buy |
339,480
+57,327
| +20% | +$3.78M | 0.05% | 272 |
|
|
2015
Q4 | $17.5M | Buy |
282,153
+183,820
| +187% | +$11.4M | 0.04% | 333 |
|
|
2015
Q3 | $6.58M | Buy |
98,333
+723
| +0.7% | +$48.4K | 0.01% | 580 |
|
|
2015
Q2 | $9.5M | Sell |
97,610
-199
| -0.2% | -$19.4K | 0.02% | 494 |
|
|
2015
Q1 | $9.14M | Sell |
97,809
-1,027
| -1% | -$96K | 0.02% | 537 |
|
|
2014
Q4 | $8.79M | Sell |
98,836
-79
| -0.1% | -$7.02K | 0.02% | 540 |
|
|
2014
Q3 | $6.83M | Sell |
98,915
-11,363
| -10% | -$785K | 0.01% | 632 |
|
|
2014
Q2 | $6.33M | Sell |
110,278
-19,432
| -15% | -$1.11M | 0.01% | 683 |
|
|
2014
Q1 | $5.14M | Buy |
129,710
+91,252
| +237% | +$3.62M | 0.01% | 743 |
|
|
2013
Q4 | $1.62M | Buy |
38,458
+328
| +0.9% | +$13.8K | ﹤0.01% | 1101 |
|
|
2013
Q3 | $1.14M | Hold |
38,130
| – | – | ﹤0.01% | 1187 |
|
|
2013
Q2 | $2.02M | Buy |
+38,130
| New | +$2.02M | 0.01% | 1050 |
|